Optimising management in Turner syndrome: From infancy to adult transfer

Archives of Disease in Childhood

Volumn 91, Issue 6, 2006, Pages 513-520

  Donaldson, M D C ^a,b   Gault, E J ^b   Tan, K W ^b   Dunger, D B ^c  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN DERIVATIVE; ETHINYLESTRADIOL; GROWTH HORMONE; NORETHISTERONE; OXANDROLONE;

CLINICAL TRIAL; CONGENITAL HEART DISEASE; DIABETES MELLITUS; DOSE RESPONSE; GENETIC ANALYSIS; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; INFANCY; INSULIN RESISTANCE; LIVER FUNCTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; THYROID DISEASE; TURNER SYNDROME; X CHROMOSOME ABERRATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; ESTROGENS; ETHINYL ESTRADIOL; FEMALE; GENOTYPE; GROWTH HORMONE; HUMANS; INFANT; PHENOTYPE; TURNER SYNDROME;

EID: 33744811403     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2003.035907     Document Type: Review

References (93)

1. Nielsen J, Wohlert M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 1991;87:81-3.
2. Cockwell A, MacKenzie M, Youings S, et al. A cytogenetic and molecular study of a series of 45,X fetuses and their parents. J Med Genet 1991;28:151-5.
3. Hook EB, Warburton D. The distribution of chromosomal genotypes associated with Turner's syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism. Hum Genet 1983;64:24-7.
4. Jacobs P, Dalton P, James R, et al. Turner syndrome: a cytogenetic and molecular study. Ann Hum Genet 1997;61:471-83.
5. Carrel L, Cottle AA, Goglin KC, et al. A first-generation X-inactivation profile of the human X chromosome. Proc Natl Acad Sci U S A 1999;96:14440-4.
6. Rao E, Weiss B, Fukami M, et al. Pseudoautosomal deletions encompassing, a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 1997;16:54-63.
7. Boucher CA, Sargent CA, Ogata T, et al. Breakpoint analysis of Turner patients with partial Xp deletions: implications for the lymphoedema gene location. J Med Genet 2001;38:591-8.
8. Ogata T, Muroya K, Matsuo N, et al. Turner syndrome and Xp deletions: clinical and molecular studies in 47 patients. J Clin Endocrinol Metab 2001;86:5498-508.
9. Zinn AR, Tonk VS, Chen Z, et al. Evidence for a Turner syndrome locus or loci at Xp11.2-p22.1. Am J Hum Genet 1998;63:1757-66.
10. Blair J, Tolmie J, Hollman A, et al. Phenotype, ovarian function, and growth in patients with 45,X/47,XXX Turner mosaicism: implications for prenatal counseling and estrogen therapy at puberty. J Pediatr 2001;139:724-8.
11. Hayward PAR, Satsangi J, Jewell DP. Inflammatory bowel disease and the X chromosome. Q J Med 1996;89:713-18.
12. Chiovato L, Larizza D, Bendinelli G, et al. Autoimmune hypothyroidsim and hyperthyroidism in patients with Turner's syndrome. Eur J Endocrinol 1996;134:568-75.
13. Kunsti J, Skuse D, Elgar K, et al. Ring-X chromosomes: their cognitive and behavioural phenotype. Ann Hum Genet 2000;64:295-305.
14. Collins AL, Cockwell AE, Jacobs PA, et al. A comparison of the clinical and cytogenetic findings in nine patients with a ring (X) cell line and 16 45,X patients. J Med Genet 1994;31:528-33.
15. Gravholt CH, Fedder J, Naeraa RW, et al. Occurrence of gonadoblastoma in females with turner syndrome and Y chromosome material: a population study. J Clin Endocrinol Metab 2000;85:3199-202.
16. Held KR, Kerber S, Kaminsky E, et al. Hypothesis: 45,X Turner syndrome does not exist. All surviving patients have sex-chromosomal mosaicism. In: Ranke MB, Rosenfeld RG, eds. Turner syndrome: growth promoting therapies. Amsterdam: Elsevier Science, 1991:15-20.
17. Turner Syndrome Support Society. Turner syndrome: lifelong guidance and support. South Shields: Harlow Printing Limited, 2002.
18. Turner Syndrome Support Society. Talking about Turner syndrome. Oxford: Oxford PharmaGenesis Ltd, 2003.
19. Stanhope R. ed. Turner syndrome: questions answered for parents and children. Guildford: A&M Publishing Ltd, 2004.
20. Stirling H, McKane A-M. Teens and Turner syndrome: what's it all about? Novo Nordisk Ltd, 2003.
21. Turner Syndrome Support Society. Turner syndrome and education: how to help your child survive and succeed at school. South Shields: Harlow Printing Limited, 2004.
22. Sybert VP. Cardiovascular malformations and complications in Turner syndrome. Pediatrics 1998;101:e11.
23. Gravholt CH. Long-term follow-up of Turner syndrome. International Growth Monitor 2004;14:2-6.
24. Nathwani NC, Unwin R, Brook CGD, et al. The influence of renal and cardiovascular abnormalities on blood pressure in Turner syndrome. Clin Endocrinol (Oxf) 2000;52:371-7.
25. Nathwani NC, Unwin R, Brook CGD, et al. Blood pressure and Turner syndrome. Clin Endocrinol (Oxf) 2000;52:363-70.
26. Lippe B, Geffner ME, Dietrich RB, et al. Renal malformations in patients with Turner syndrome: imaging in 141 patients. Pediatrics 1988;82:852-6.
27. Flynn MT, Ekstrom L, De Arce M, et al. Prevalence of renal malformation in Turner syndrome. Pediatr Nephrol 1996;10:498-500.
28. Elsheikh M, Hodgson HJF, Wass JAH, et al. Hormone replacement therapy may improve hepatic function in women with Turner's syndrome. Clin Endocrinol 2001;55:227-31.
29. Gravholt CH. Medical problems of adult Turner's syndrome. Norm Res 2001;56:44-50.
30. Gravholt CH, Juul S, Naeraa RW, et al. Morbidity in Turner syndrome. J Clin Epidemiol 1998;51:147-58.
31. Salerno M, Di Maio S, Gasparini N, et al. Liver abnormalities in Turner syndrome. Eur J Pediatr 1999;158:618-23.
32. Starke M, Wikland KA, Möller A. Parents' descriptions of development and problems associated with infants with Turner syndrome: A retrospective study. J Paediatr Child Health 2003;39(4):293-8.
33. Mathisen B, Reilly S, Skuse D. Oral-motor dysfunction and feeding disorders of infants with Turner syndrome. Dev Med Child Neurol 1992;34:141-9.
34. Findlay CA, Donaldson M. How often should we screen for hypothyroidism in girls with Turner's syndrome? Arch Dis Child 1998;78:500a.
35. Sas TCJ, de Muinck Keizer-Schrama SMPF, Stijnen T, et al. Carbohydrate metabolism during long-term growth hormone (GH) Treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response study. J Clin Endocrinol Metab 2000;141:769-75.
36. Elsheikh M, Dunger DB, Conway GS, et al. Turner's syndrome in adulthood. Endocr Rev 2002;23:120-40.
37. Barrenäs M-L, Landin-Wilhelmsen K, Hanson C. Ear and hearing in relation to genotype and growth in Turner syndrome. Hear Res 2000;144:21-8.
38. Sculerati N, Ledesma-Medina J, Finegold DN, et al. Otitis media and hearing loss in Turner syndrome. Arch Otolaryngol Head Neck Surg 1990;116:704-7.
39. Stenberg AE, Nylén O, Windh M, et al. Otoiogical problems in children with Turner's syndrome. Hear Res 1998;124:85-90.
40. Chrousos GA, Ross JL, Chrousos G, et al. Ocular findings in Turner syndrome. Ophthalmology 1984;91:926-8.
41. Adhikary HP. Ocular manifestations of Turner's syndrome. Trans Ophthalmol Soc U K 1981;101:395-6.
42. Blethen SL, Allen DB, Graves D, et al. Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National Cooperative Growth Study experience. J Clin Endocrinol Metab 1996;81:1704-10.
43. Findlay CA, Donaldson MD, Watt G. Foot problems in Turner's syndrome. J Pediatr 2001;138:775-7.
44. Hikade KR, Bitar GJ, Edgerton MT, et al. Modified Z-plasty repair of webbed neck deformity seen in Turner and Klippel-Feil syndrome. Cleft Palate Craniofac J 2002;39:261-6.
45. Swillen A, Fryns JP, Kleczlowska A, et al. Intelligence, behaviour and psychosocial development in Turner syndrome. A cross-sectional study of 50 pre-adolescent and adolescent girls [4-20 years]. Genet Couns 1993;4:7-18.
46. Rovet J, Szekely C, Hockenberry MN. Specific arithmetic calculation deficits in children with Turner syndrome. J Clin Exp Neuropsychol 1994;16:820-39.
47. Mazzocco MM. A process approach to describing mathematics difficulties in girls with Turner syndrome. Pediatrics 1998;102:492-6.
48. Rovet JF. The psychoeducational characteristics of children with Turner syndrome. J Learn Disabil 1993;26:333-41
49. Siegel PT, Clopper R, Stabler B. The psychological consequences of Turner syndrome and review of the National Cooperative Growth Study Psychological Substudy. Pediatrics 1998;102:488-91.
50. Boman UW, Möller A, Albertsson-Wikland K. Psychological aspects of Turner syndrome. J Psychosom Obstet Gynecol 1998;19:1-18.
51. McCauley E, Feuillan P, Kushner H, et al. Psychosocial development in adolescents with Turner syndrome. J Dev Behav Pediatr 2001;22:360-5.
52. Skuse DH, James RS, Bishop DVM, et al. Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. Nature 1997;387:705-8.
53. Rochiccioli P, David M, Malpuech G, et al. Study of final height in Turner's syndrome: ethnic and genetic influences. Acta Paediatr 1994;83:305-8.
54. Bidwell JP, Bennet GC, Bell MJ, et al. Leg lengthening for short stature in Turner's syndrome. J Bone Joint Surg Br 2000;82-B:1174-6.
55. Guyda HJ. Four decades of growth hormone therapy for short children: what have we achieved? J Clin Endocrinol Metab 1999;84:4307-16.
56. Canadian Growth Hormone Advisory Committee. Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab 2005;90:3360-6.
57. Betts PR, Butler GE, Donaldson MD, et al. A decade of growth hormone treatment in girls with Turner syndrome in the UK. Arch Dis Child 1999;80:221-5.
58. Nilsson KO, Albertsson-Wikland K, Aim J, et al. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone. J Clin Endocrinol Metab 1996;81:635-40.
59. Rosenfeld RG, Attie KM, Frane J, et al. Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J Pediatr 1998;132:319-24.
60. Gault EJ, Paterson WF, Young D, et al. Improved final height in Turner's syndrome following growth-promoting treatment at a single centre. Acta Paediatr 2003;92:1033-8.
61. Rochiccioli P, Battin J, Bertrand AM, et al. Final height in Turner syndrome patients treated with growth hormone. Horm Res 1995;44:172-6.
62. Massa G, Heinrichs C, Verlinde M, et al. Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height. J Clin Endocrinol Metab 2003;88:4168-74.
63. Reiter EO, Blethen SL, Baptista J, et al. Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome. J Clin Endocrinol Metab 2001;86:1936-41.
64. Quigley CA, Crowe BJ, Anglin DG, et al. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-centre trial to near-final height. J Clin Endocrinol Metab 2002;87:2033-41.
65. Ranke MB, Partsch CJ, Lindberg A, et al. Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-Up Study 2001. Eur J Endocrinol 2002;147:625-33.
66. Chernausek SD, Attie KM. Role of oestrogen therapy in the management of short stature in Turner syndrome. Acta Paediatr Suppl 1999;433:130-2.
67. Price DA, Ranke MB. Growth hormone in Turner syndrome. Arch Dis Child 2001;84:531.
68. Ranke MB, Lindberg A, Chatelain P, et al. Turner syndrome: demography, auxology and growth during growth hormone therapy in KIGS. In: Ranke MB, Wilton P, eds. Growth hormone therapy in KICS-10 years experience. Heidelberg: Johann Ambrosius Barth Verlag, 1999:245-58.
69. Albertsson-Wikland K, Rosberg S. Pattern of spontaneous growth hormone secretion in Turner syndrome. In: Ranke MB, Rosenfeld RG, eds. Turner syndrome: growth promoting therapies. Amsterdam: Elsevier Science, 1991:23-8.
70. Pirazzoli P, Mazzanti L, Bergamaschi R, et al. Reduced spontaneous growth hormone secretion in patients with Turner's syndrome. Acta Paediatr 1999;88:610-13.
71. Tanaka T, Hibi I, Shizume K, et al. GH secretion capacity in Turner syndrome and its influence on the effect of GH treatment. In: Ranke MB, Rosenfeld RG, eds. Turner syndrome: growth promoting therapies. Amsterdam: Elsevier Science, 1991:41-5.
72. Cavallo L, Gurrado R. Endogenous growth hormone secretion does not correlate with growth in patients with Turner's syndrome. J Pediatr Endocrinol Metab 1999;12:623-7.
73. Ranke MB, Lindberg A, Chatelain P, et al. Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. J Clin Endocrinol Metab 2000;85:4212-18.
74. Corel J-C, Mathivon L, Gendrel C, et al. Near normalization of final height with adapted doses of growth hormone in Turner's syndrome. J Clin Endocrinol Metab 1998;83:1462-6.
75. van Pareren YK, de Muinck Keizer-Schrama S, Stijnen T, et al. Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab 2003;88:1119-25.
76. Donaldson MD. Growth hormone therapy in Turner syndrome-current uncertainties and future strategies. Horm Res 1997;48:35-44.
77. Das U, Whatmore AJ, Khosravi J, et al. IGF-I and IGF-binding protein-3 measurements on filter paper blood spots in children and adolescents on GH treatment: use in monitoring and as markers of growth performance. Eur J Endocrinol 2003;149:179-85.
78. Tillmann V, Patel L, Gill MS, et al. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth. Clin Endocrinol 2000;53:329-36.
79. Stahnke N, Keller E, Landy H, et al. Favourable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age. J Pediatr Endocrinol Metab 2002;15:129-38.
80. Bath LE, Critchley HOD, Kelnar CJH, et al. Choice of hormone replacement therapy in young women with ovarian failure. Clin Endocrinol 2001;55:697-8.
81. Kiess W, Conway G, Ritzen M, et al. Induction of puberty in the hypogonadal girl-practices and attitudes of pediatric endocrinologists in Europe. Horm Res 2002;57:66-71.
82. Cacciari E, Mazzanti L, Italian Study Group for Turner Syndrome. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. J Clin Endocrinol Metab 1999;84:4510-15.
83. Tarani L, Lampariello S, Raguso G, et al. Pregnancy in patients with Turner's syndrome: six new cases and review of literature. Gynecol Endocrinol 1998;12:83-7.
84. Khastgir G, Abdalla H, Thomas A, et al. Oocyte donation in Turner's syndrome: an analysis of the factors affecting the outcome. Hum Reprod 1997;12:279-85.
85. Hovatta O. Methods for cryopreservation of human ovarian tissue. Reprod Biomed Online 2005;10:729-34.
86. Beckman A, Conway GS, Cadge B. Audiological features of Turner's syndrome in adults. Int J Audiol 2004;43:533-44.
87. El Mansoury M, Bryman I, Berntorp K, et al. Hypothyroidism is common in Turner syndrome: results of a five-year follow-up. J Clin Endocrinol Metab 2005;90:2131-5.
88. Paterson WF, Hollman AS, Donaldson MDC. Poor uterine development in Turner syndrome with oral oestrogen therapy. Clin Endocrinol 2002;56:359-65.
89. Snajderova M, Mardesic T, Lebl J, et al. The uterine length in women with Turner syndrome reflects the postmenarcheal daily estrogen dose. Horm Res 2003;60:198-204.
90. Elsheikh M, Casadei B, Conway GS, et al. Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome. Clin Endocrinol 2001;54:69-73.
91. Lin AE, Lippe B, Rosenfeld RG. Further delineation of aortic dilation, dissection and rupture in patients with Turner syndrome. Pediatrics 1998;102:e12.
92. Ostberg JE, Brookes JAS, McCarthy C, et al. A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome. J Clin Endocrinol Metab 2004;89:5966-71.
93. Conway GS, Elsheikh M, Cadge B, et al. Adult Turner follow-up-the Middlesex experience. In: Saenger P, Pasquino AM, eds. Optimizing health care for Turner patients in the 21st century. Amsterdam: Elsevier Science, 2000:295-306.